Challenges and Innovations in Pharmacological Treatment for ADHD and of Stimulant Use Disorders

1. Discontinuation and reinitiation of pharmacological treatment for ADHD medication among young people with comorbid ADHD and substance use disorder (SUD) – Andrea Johansson Capusan
2. Medical Hazards of Stimulant use Disorder – Soheir Helmy Elghonemy
3. Combination oral naltrexone/bupropion for methamphetamine use disorder, an open-label pilot study – Nicholas Lintzeris